Khaled M. Darwish

1.8k total citations · 1 hit paper
72 papers, 1.4k citations indexed

About

Khaled M. Darwish is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Khaled M. Darwish has authored 72 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 16 papers in Organic Chemistry and 13 papers in Pharmacology. Recurrent topics in Khaled M. Darwish's work include Computational Drug Discovery Methods (13 papers), Synthesis and biological activity (9 papers) and Analytical Methods in Pharmaceuticals (8 papers). Khaled M. Darwish is often cited by papers focused on Computational Drug Discovery Methods (13 papers), Synthesis and biological activity (9 papers) and Analytical Methods in Pharmaceuticals (8 papers). Khaled M. Darwish collaborates with scholars based in Egypt, Saudi Arabia and United States. Khaled M. Darwish's co-authors include Sameh S. Elhady, Ahmed A. Al‐Karmalawy, Ismail Salama, Samia M. Mostafa, Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly, Mohammed A. Dahab, Tarek S. Ibrahim and Wael A. H. Hegazy and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and International Journal of Pharmaceutics.

In The Last Decade

Khaled M. Darwish

69 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor

2021 209 citations Ahmed A. Al‐Karmalawy, Sameh S. Elhady et al. profile →

Peers

Countries citing papers authored by Khaled M. Darwish

Since Specialization

Citations

This map shows the geographic impact of Khaled M. Darwish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khaled M. Darwish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khaled M. Darwish more than expected).

Fields of papers citing papers by Khaled M. Darwish

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khaled M. Darwish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khaled M. Darwish. The network helps show where Khaled M. Darwish may publish in the future.

Co-authorship network of co-authors of Khaled M. Darwish

This figure shows the co-authorship network connecting the top 25 collaborators of Khaled M. Darwish. A scholar is included among the top collaborators of Khaled M. Darwish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khaled M. Darwish. Khaled M. Darwish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Topical loratadine-loaded invasomal gel repurposed for vulvovaginal candidiasis; in vitro, in silico, ex vivo, and in vivo studies 2025 ·International Journal of Pharmaceutics ·(unknown), (unknown), Rehab Abdelmonem, Maha M. Abdel‐Fattah, Khaled M. Darwish, (unknown), Menna M. Abdellatif	1
2	Discovery of new benzothiazole-1,2,3-triazole hybrid-based hydrazone/thiosemicarbazone derivatives as potent EGFR inhibitors with cytotoxicity against cancer 2025 ·RSC Advances ·Ateyatallah Aljuhani, Mohamed S. Nafie, (unknown), Mosa Alsehli, Sanaa K. Bardaweel, Khaled M. Darwish, Shaya Y. Al‐Raqa, Mohamed Reda Aouad, Nadjet Rezki	9
3	Green innovation in analytical chemistry: A sustainable densitometric HPTLC approach for the distinctive separation and quantification of structurally related abused drugs - tramadol, tapentadol, and venlafaxine - in seized pharmaceutical dosage forms 2024 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Khaled M. Darwish, Samia M. Mostafa, Mohamed Saleh Elgawish	5
4	Unveiling the Multifaceted Capabilities of Endophytic Aspergillus flavus Isolated from Annona squamosa Fruit Peels against Staphylococcus Isolates and HCoV 229E—In Vitro and In Silico Investigations 2024 ·Pharmaceuticals ·(unknown), Wafaa M. Elkady, (unknown), Khaled M. Darwish, Sameh S. Elhady, (unknown)	3
5	In vivo determination of analgesic and anti-inflammatory activities of isolated compounds from Cleome amblyocarpa and molecular modelling for the top active investigated compounds 2024 ·RSC Advances ·(unknown), (unknown), (unknown), (unknown), Khaled M. Darwish, Sameh S. Elhady, (unknown), Safwat A. Ahmed	5
6	Synthesis and characterization of mixed-ligand Co(II) complexes with gabapentin or pregabalin and diimine coligands: DNA interaction, antibacterial, antifungal and molecular docking studies 2024 ·Journal of Molecular Structure ·(unknown), (unknown), Khaled M. Darwish	3
7	Design and synthesis of chromene-1,2,3-triazole benzene sulfonamide hybrids as potent carbonic anhydrase-IX inhibitors against prostate cancer 2024 ·RSC Medicinal Chemistry ·(unknown), Mohamed S. Nafie, (unknown), Wafa Hourani, Ateyatallah Aljuhani, Khaled M. Darwish, (unknown), Nadjet Rezki, Mohamed Reda Aouad	10
8	Dual SARS-CoV-2 and MERS-CoV inhibitors from Artemisia monosperma : isolation, structure elucidation, molecular modelling studies, and in vitro activities 2024 ·Organic & Biomolecular Chemistry ·(unknown), (unknown), (unknown), (unknown), Osama G. Mohamed, Khaled M. Darwish, Ashootosh Tripathi, Safwat A. Ahmed	0
9	Unveiling Pharmacokinetics and Drug Interaction of Linagliptin and Pioglitazone HCl in Rat Plasma Using LC-MS/MS 2024 ·Chemical Research in Toxicology ·(unknown), Sherin F. Hammad, Khaled M. Darwish, Mohamed Saleh Elgawish	1
10	Exploring the Synergistic Effect of Bergamot Essential Oil with Spironolactone Loaded Nano-Phytosomes for Treatment of Acne Vulgaris: In Vitro Optimization, In Silico Studies, and Clinical Evaluation 2023 ·Pharmaceuticals ·Rofida Albash, Noha M. Badawi, Maha M. Abdel‐Fattah, (unknown), (unknown), (unknown), Khaled M. Darwish, (unknown), Sameh S. Elhady, Shaimaa Mosallam	21
11	Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy 2023 ·Biology ·Mohamed A. Soltan, Muhammad Alaa Eldeen, (unknown), Reda F. A. Abdelhameed, Fawziah A. Al‐Salmi, Eman Fayad, (unknown), (unknown), Refaat A. Eid, (unknown), Mubarak Al‐Shraim, Amr Negm, Ahmed E. Noreldin, Khaled M. Darwish	7
12	Computational and Biological Evaluation of β-Adrenoreceptor Blockers as Promising Bacterial Anti-Virulence Agents 2022 ·Pharmaceuticals ·Ahmad J. Almalki, Tarek S. Ibrahim, Sameh S. Elhady, Wael A. H. Hegazy, Khaled M. Darwish	40
13	Hiring of the Anti-Quorum Sensing Activities of Hypoglycemic Agent Linagliptin to Alleviate the Pseudomonas aeruginosa Pathogenesis 2022 ·Microorganisms ·Maan T. Khayat, Tarek S. Ibrahim, Khaled M. Darwish, Ahdab N. Khayyat, Majed Alharbi, El‐Sayed Khafagy, Mohamed A. M. Ali, Wael A. H. Hegazy, Hisham A. Abbas	20
14	Repurposing α-Adrenoreceptor Blockers as Promising Anti-Virulence Agents in Gram-Negative Bacteria 2022 ·Antibiotics ·Ahmad J. Almalki, Tarek S. Ibrahim, Sameh S. Elhady, Khaled M. Darwish, Wael A. H. Hegazy	34
15	Phenolics from Chrozophora oblongifolia Aerial Parts as Inhibitors of α-Glucosidases and Advanced Glycation End Products: In-Vitro Assessment, Molecular Docking and Dynamics Studies 2022 ·Biology ·Hossam M. Abdallah, (unknown), (unknown), Khaled M. Darwish, Ali M. El‐Halawany, Mardi M. Algandaby, Sabrin R. M. Ibrahim, Gamal A. Mohamed, Ashraf B. Abdel‐Naim, Abdulrahman E. Koshak, Peter Proksch, Sameh S. Elhady	16
16	Molecular Docking and Dynamics Simulation Study of Hyrtios erectus Isolated Scalarane Sesterterpenes as Potential SARS-CoV-2 Dual Target Inhibitors 2021 ·Biology ·Sameh S. Elhady, Reda F. A. Abdelhameed, (unknown), Abdulrahman M. Alahdal, (unknown), Ahmad J. Almalki, (unknown), Safwat A. Ahmed, Amgad I. M. Khedr, Khaled M. Darwish	49
17	Deciphering the molecular basis of the kappa opioid receptor selectivity: A Molecular Dynamics study 2021 ·Journal of Molecular Graphics and Modelling ·(unknown), (unknown), Khaled M. Darwish, (unknown), Amar G. Chittiboyina, Mohamed A. Helal	19
18	In Silico and In Vitro Studies for Benzimidazole Anthelmintics Repurposing as VEGFR-2 Antagonists: Novel Mebendazole-Loaded Mixed Micelles with Enhanced Dissolution and Anticancer Activity 2021 ·ACS Omega ·Ayman Abo Elmaaty, Khaled M. Darwish, Amani Chrouda, (unknown), Mohamed A. Tantawy, Sameh S. Elhady, Afzal B. Shaik, Muhamad Mustafa, Ahmed A. Al‐Karmalawy	73
19	Repurposing of Sitagliptin- Melittin Optimized Nanoformula against SARS-CoV-2; Antiviral Screening and Molecular Docking Studies 2021 ·Pharmaceutics ·Mohammed W. Al-Rabia, Nabil A. Alhakamy, Osama A. A. Ahmed, Khalid Eljaaly, Ahmed L. Alaofi, Ahmed Mostafa, Hani Z. Asfour, Ahmed Aldarmahi, Khaled M. Darwish, Tarek S. Ibrahim, Usama A. Fahmy	33
20	Synthesis, biological evaluation, and molecular docking investigation of benzhydrol- and indole-based dual PPAR-γ/FFAR1 agonists 2018 ·Bioorganic & Medicinal Chemistry Letters ·Khaled M. Darwish, Ismail Salama, Samia M. Mostafa, Mohamed S. Gomaa, El‐Sayed Khafagy, Mohamed A. Helal	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact